---
document_datetime: 2024-12-18 11:30:03
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sapropterin-dipharma-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: sapropterin-dipharma-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.5043178
conversion_datetime: 2025-12-18 23:39:35.800776
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Sapropterin Dipharma

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0014              | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                               | 19/09/2024                          |                                             | SmPC, Labelling and PL           |           |
| IB/0017/G            | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF A.4 - Administrative change - Change in the name | 18/09/2024                          | n/a                                         |                                  |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | supplier of the AS, starting material, reagent or used in the manufacture of the AS or of a novel excipient                                                                                                                                                                                                                                                                                                                                                                       |            |     | or intermediate manufacturer   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------------|
| IA/0016/G | This was an application for a group of variations. B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold originally approved batch size                                                                                                                          | 31/07/2024 | n/a | compared to the                |
| IB/0013/G | This was an application for a group of variations. B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved | 01/02/2024 | n/a | manufacturer                   |
| IB/0012/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement                                                                                                                                                                                                                                                                               | 26/05/2023 | n/a |                                |

<div style=\"page-break-after: always\"></div>

|           | or a starting material/intermediate B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                           |            |            |                     | or addition) for the AS   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------|---------------------------|
| IB/0011/G | This was an application for a group of variations. B.II.z - Quality change - Finished product - Other variation B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor an approved test procedure | 21/04/2023 | n/a        |                     | changes to                |
| II/0010   | B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                                                                                                                                                                                                                                                                                                                                               | 16/02/2023 | n/a        |                     |                           |
| T/0009    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 19/12/2022 | 30/01/2023 | SmPC, Labelling and |                           |

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                        |            |            | PL              |                                                                                                                                                                                                                                                                                                                                                                                  |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0008     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                           | 13/12/2022 | 30/01/2023 | SmPC and PL     |                                                                                                                                                                                                                                                                                                                                                                                  |
| IB/0007/G   | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) | 17/11/2022 | 30/01/2023 | SmPC            | Product information section 6.3 is updated to reflect the shelf-life extension of the finished product Sapropterin Dipharma 100 mg soluble tablets (EU/1/21/1620/001-002), Sapropterin Dipharma 100 mg powder for oral solution (EU/1/21/1620/003) and Sapropterin Dipharma 500 mg powder for oral solution (EU/1/21/1620/004) as packaged for sale from 24 months to 36 months. |
| IA/0006     | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                             | 16/09/2022 | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                  |
| IB/0005     | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                           | 26/08/2022 | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                  |
| IAIN/0004/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                       | 20/06/2022 | 30/01/2023 | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

|         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing   |            |            |             | site   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------|
| IB/0001 | C.I.6.b - Change(s) to therapeutic indication(s) - Deletion of a therapeutic indication                                                                                                                                                  | 08/04/2022 | 05/05/2022 | SmPC and PL |        |
| IB/0002 | B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method                                                    | 01/04/2022 | n/a        |             |        |
| IA/0003 | B.II.b.4.b - Change in the batch size (including batch size ranges) of the finished product - Downscaling down to 10-fold                                                                                                                | 14/03/2022 | n/a        |             |        |